The following pages link to VEGF receptor
External toolsShowing 47 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Endometriosis (links | edit)
- Hepatocellular carcinoma (links | edit)
- Receptor (biochemistry) (links | edit)
- Soluble fms-like tyrosine kinase-1 (links | edit)
- Itaconic acid (links | edit)
- Receptors, vascular endothelial growth factor (redirect page) (links | edit)
- VEGF Receptor (redirect page) (links | edit)
- VEGFRs (redirect page) (links | edit)
- VEGF Receptors: Flt-1 & KDR/Flk-1 (redirect page) (links | edit)
- Vascular endothelial growth factor receptor (redirect page) (links | edit)
- Dehydroepiandrosterone (links | edit)
- Growth factor (links | edit)
- Insulin (links | edit)
- Insulin-like growth factor (links | edit)
- Integrin (links | edit)
- Testosterone (links | edit)
- Tyrosine kinase (links | edit)
- Erythropoietin (links | edit)
- Dexamethasone (links | edit)
- Thrombopoietin (links | edit)
- Imatinib (links | edit)
- Filgrastim (links | edit)
- Amitriptyline (links | edit)
- Brain-derived neurotrophic factor (links | edit)
- Trastuzumab (links | edit)
- Insulin-like growth factor 1 (links | edit)
- Adult neurogenesis (links | edit)
- Gefitinib (links | edit)
- Platelet-derived growth factor (links | edit)
- Neurotrophin (links | edit)
- Wnt signaling pathway (links | edit)
- Transforming growth factor (links | edit)
- Epidermal growth factor (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Vascular endothelial growth factor (links | edit)
- Epidermal growth factor receptor (links | edit)
- Glucose-6-phosphate isomerase (links | edit)
- Neuregulin (links | edit)
- Fibroblast growth factor 2 (links | edit)
- Amphiregulin (links | edit)
- Nerve growth factor (links | edit)
- Pegfilgrastim (links | edit)
- Erlotinib (links | edit)
- Insulin-like growth factor 2 (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- Prasterone (links | edit)
- HER2 (links | edit)
- Palifermin (links | edit)
- Sorafenib (links | edit)
- Colony-stimulating factor (links | edit)
- Sunitinib (links | edit)
- K252a (links | edit)
- Fibroblast growth factor (links | edit)
- Fibroblast growth factor 1 (links | edit)
- FGF3 (links | edit)
- Hemopoietic growth factor (links | edit)
- Lapatinib (links | edit)
- Pleiotrophin (links | edit)
- Glial cell line-derived neurotrophic factor (links | edit)
- Oncomodulin (links | edit)
- Sargramostim (links | edit)
- Tropomyosin receptor kinase A (links | edit)
- Tropomyosin receptor kinase B (links | edit)
- Axel Ullrich (links | edit)
- Low-affinity nerve growth factor receptor (links | edit)
- Tropomyosin receptor kinase C (links | edit)
- Fibroblast growth factor 23 (links | edit)
- Insulin-like growth factor 1 receptor (links | edit)
- Dehydroepiandrosterone sulfate (links | edit)
- Neurotrophic factors (links | edit)
- Receptor tyrosine kinase (links | edit)
- Ephrin receptor (links | edit)
- Neurotrophin-3 (links | edit)
- Angiopoietin (links | edit)
- Erythropoietin receptor (links | edit)
- Somatomedin receptor (links | edit)
- Platelet-derived growth factor receptor (links | edit)
- Fibroblast growth factor receptor (links | edit)
- Neurturin (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- Ranibizumab (links | edit)
- Ciliary neurotrophic factor (links | edit)
- Hepatocyte growth factor (links | edit)
- Glia maturation factor (links | edit)
- Panitumumab (links | edit)
- Vandetanib (links | edit)
- Midkine (links | edit)
- Pituitary adenylate cyclase-activating peptide (links | edit)
- Adrenomedullin (links | edit)
- Pegaptanib (links | edit)
- Insulin-like growth factor-binding protein (links | edit)
- CTGF (links | edit)
- Idiopathic pulmonary fibrosis (links | edit)
- Pertuzumab (links | edit)
- Ertumaxomab (links | edit)
- KIT (gene) (links | edit)
- TGF alpha (links | edit)
- Neurotrophin-4 (links | edit)
- Matuzumab (links | edit)
- Nimotuzumab (links | edit)
- Zalutumumab (links | edit)
- Semaxanib (links | edit)
- Fibroblast growth factor receptor 2 (links | edit)
- Insulin-like growth factor 2 receptor (links | edit)
- Keratinocyte growth factor (links | edit)
- Cediranib (links | edit)
- VEGF receptor (links | edit)
- Persephin (links | edit)
- Artemin (links | edit)
- GDNF family of ligands (links | edit)
- Angiopoietin receptor (links | edit)
- Angiopoietin 1 (links | edit)
- ANGPT2 (links | edit)
- RET proto-oncogene (links | edit)
- Stem cell factor (links | edit)
- Receptor activity-modifying protein (links | edit)
- RAMP1 (links | edit)
- RAMP2 (links | edit)
- RAMP3 (links | edit)
- Mecasermin rinfabate (links | edit)
- N-Acetylserotonin (links | edit)
- Neuregulin 1 (links | edit)
- Ancestim (links | edit)
- Fibroblast growth factor receptor 1 (links | edit)
- Fibroblast growth factor receptor 3 (links | edit)
- Pazopanib (links | edit)
- Growth factor receptor (links | edit)
- ErbB (links | edit)
- Heparin-binding EGF-like growth factor (links | edit)
- Epiregulin (links | edit)
- Epigen (links | edit)
- Betacellulin (links | edit)
- Ephrin (links | edit)
- FMS-like tyrosine kinase 3 ligand (links | edit)
- Becaplermin (links | edit)
- PDGFRB (links | edit)
- IGFBP3 (links | edit)
- Kinase insert domain receptor (links | edit)
- ERBB3 (links | edit)
- ERBB4 (links | edit)
- IGFBP2 (links | edit)
- IGFBP5 (links | edit)
- Fibroblast growth factor receptor 4 (links | edit)
- Ephrin B2 (links | edit)
- IGFBP4 (links | edit)
- PDGFA (links | edit)
- CALCRL (links | edit)
- Ephrin B1 (links | edit)
- ADCYAP1R1 (links | edit)
- GFRA1 (links | edit)
- Lenograstim (links | edit)
- Molgramostim (links | edit)
- PDGFB (links | edit)
- Vascular endothelial growth factor C (links | edit)
- IGFBP6 (links | edit)
- EPH receptor B2 (links | edit)
- Trk receptor (links | edit)
- EPH receptor A2 (links | edit)
- Axitinib (links | edit)
- IGFBP1 (links | edit)
- FGF7 (links | edit)
- Placental growth factor (links | edit)
- EPH receptor B4 (links | edit)
- Thrombopoietin receptor (links | edit)
- Ephrin A1 (links | edit)
- MST1R (links | edit)
- EPH receptor A4 (links | edit)
- EPH receptor B1 (links | edit)
- IGFBP7 (links | edit)
- FGF10 (links | edit)
- C-fos-induced growth factor (links | edit)
- EPH receptor A3 (links | edit)
- Fibroblast growth factor 8 (links | edit)
- EPHB6 (links | edit)
- EPHA8 (links | edit)
- EPHA7 (links | edit)
- FGF9 (links | edit)
- EPH receptor A5 (links | edit)
- Hepatoma-derived growth factor (links | edit)
- Ephrin A4 (links | edit)
- FGF4 (links | edit)
- FGF5 (links | edit)
- MST1 (links | edit)
- Ephrin A2 (links | edit)
- Ephrin A3 (links | edit)
- Ephrin B3 (links | edit)
- EPH receptor A1 (links | edit)
- EPHB3 (links | edit)
- FGF18 (links | edit)
- Proteoglycan 4 (links | edit)
- PDGFC (links | edit)
- FGF19 (links | edit)
- EPHA6 (links | edit)
- Vascular endothelial growth factor B (links | edit)
- PDGFD (links | edit)
- FGF14 (links | edit)
- ANGPT4 (links | edit)
- Fibroblast growth factor receptor-like 1 (links | edit)
- FGF13 (links | edit)
- GFRA3 (links | edit)
- FGF6 (links | edit)
- FGF12 (links | edit)
- GFRA2 (gene) (links | edit)
- Neuregulin 2 (links | edit)
- FGF17 (links | edit)
- Vascular endothelial growth factor A (links | edit)
- Ciliary neurotrophic factor receptor (links | edit)
- Platelet-derived growth factor receptor A (links | edit)
- Lestaurtinib (links | edit)
- CSPG5 (links | edit)
- Fibroblast growth factor 21 (links | edit)
- Mecasermin (links | edit)
- Ponazuril (links | edit)
- Gossypetin (links | edit)
- Bosutinib (links | edit)
- Neuregulin 3 (links | edit)
- Neuregulin 4 (links | edit)
- Afatinib (links | edit)
- Neurotrophic factor receptor (links | edit)
- FGF11 (links | edit)
- Prasterone sulfate (links | edit)
- FGF16 (links | edit)
- FGF22 (links | edit)
- FGF20 (links | edit)
- Cixutumumab (links | edit)
- Ramucirumab (links | edit)
- Alacizumab pegol (links | edit)
- Tanezumab (links | edit)
- Figitumumab (links | edit)
- Neratinib (links | edit)
- Necitumumab (links | edit)
- Robatumumab (links | edit)
- RTK class III (links | edit)
- Thyroid cancer (links | edit)
- Toceranib (links | edit)
- Renalase (links | edit)
- Diosmetin (links | edit)
- Lenvatinib (links | edit)
- Regorafenib (links | edit)
- Apatinib (links | edit)
- Grandinin (links | edit)
- Olaratumab (links | edit)
- Mubritinib (links | edit)
- Tyrosine kinase inhibitor (links | edit)
- Crizotinib (links | edit)
- Tivozanib (links | edit)
- Vemurafenib (links | edit)
- Crenolanib (links | edit)
- Quizartinib (links | edit)
- Trastuzumab emtansine (links | edit)
- Motesanib (links | edit)
- Nintedanib (links | edit)
- Cabozantinib (links | edit)
- Ponatinib (links | edit)
- Selumetinib (links | edit)
- AEE788 (links | edit)
- Brigatinib (links | edit)
- Foretinib (links | edit)
- Dalotuzumab (links | edit)
- Ficlatuzumab (links | edit)
- Flanvotumab (links | edit)
- Fulranumab (links | edit)
- Ganitumab (links | edit)
- Icrucumab (links | edit)
- Onartuzumab (links | edit)
- Teprotumumab (links | edit)
- Rilotumumab (links | edit)
- Canertinib (links | edit)
- C-Met inhibitor (links | edit)
- Ephrin A5 (links | edit)
- Brivanib alaninate (links | edit)
- Fasinumab (links | edit)
- Masitinib (links | edit)
- Patritumab (links | edit)
- Nesvacumab (links | edit)
- Linsitinib (links | edit)
- Dusigitumab (links | edit)
- Trametinib (links | edit)
- Dabrafenib (links | edit)
- FGF15 (links | edit)
- FGF15/19 (links | edit)
- EPHA10 (links | edit)
- Imgatuzumab (links | edit)
- Duligotuzumab (links | edit)
- Futuximab (links | edit)
- Tovetumab (links | edit)
- Sprifermin (links | edit)
- Encorafenib (links | edit)
- Norwogonin (links | edit)
- Cobimetinib (links | edit)
- ALTO-100 (links | edit)
- Amitriptyline/perphenazine (links | edit)
- Growth factor receptor inhibitor (links | edit)
- Radotinib (links | edit)
- Icotinib (links | edit)
- Dacomitinib (links | edit)
- Ceritinib (links | edit)
- GFRA4 (links | edit)
- GFRα (links | edit)
- Tropoflavin (links | edit)
- HIOC (links | edit)
- Binimetinib (links | edit)
- Emibetuzumab (links | edit)
- Seribantumab (links | edit)
- Evinacumab (links | edit)
- Cerebrolysin (links | edit)
- IGF-1 LR3 (links | edit)
- Des(1-3)IGF-1 (links | edit)
- T-cell growth factor (links | edit)
- Dihexa (links | edit)
- Tavilermide (links | edit)
- Osimertinib (links | edit)
- Alectinib (links | edit)
- Anti-VEGF (links | edit)
- Deoxygedunin (links | edit)
- ANA-12 (links | edit)
- LM22A-4 (links | edit)
- Cyclotraxin B (links | edit)
- R7 (drug) (links | edit)
- 7,8,3'-Trihydroxyflavone (links | edit)
- Eutropoflavin (links | edit)
- Mirvetuximab soravtansine (links | edit)
- Rociletinib (links | edit)
- Entrectinib (links | edit)
- Brolucizumab (links | edit)
- Capmatinib (links | edit)
- Trofinetide (links | edit)
- Testosterone (medication) (links | edit)
- Tesevatinib (links | edit)
- Prasterone enanthate (links | edit)
- Olmutinib (links | edit)
- Lorlatinib (links | edit)
- Larotrectinib (links | edit)
- Tucatinib (links | edit)
- BNN-20 (links | edit)
- BNN-27 (links | edit)
- Cenegermin (links | edit)
- Murodermin (links | edit)
- Nepidermin (links | edit)
- Trafermin (links | edit)
- Tepotinib (links | edit)
- R13 (drug) (links | edit)
- Faricimab (links | edit)
- Estradiol valerate/prasterone enanthate (links | edit)
- Testosterone propionate/testosterone cypionate/prasterone (links | edit)
- Trastuzumab deruxtecan (links | edit)
- Avapritinib (links | edit)
- Cluster of Excellence Frankfurt Macromolecular Complexes (links | edit)
- Pemigatinib (links | edit)
- Selpercatinib (links | edit)
- Ripretinib (links | edit)
- Pertuzumab/trastuzumab/hyaluronidase (links | edit)
- Lipegfilgrastim (links | edit)
- Trastuzumab/hyaluronidase (links | edit)
- Pralsetinib (links | edit)
- Amivantamab (links | edit)
- Infigratinib (links | edit)
- Asciminib (links | edit)
- Fruquintinib (links | edit)
- Repotrectinib (links | edit)
- Fosgonimeton (links | edit)
- ACD856 (links | edit)
- Tinengotinib (links | edit)
- User:Amyahn95/sandbox (links | edit)
- User:AlphaUniform91/cerebrolysin (links | edit)
- User:I enjoy sandwiches/cerebrolysin (links | edit)
- Misplaced Pages:WikiProject Medicine/Dermatology task force/Missing articles/LeBoit (links | edit)
- Template:Growth factor receptor modulators (links | edit)
- VEGFR1 (links | edit)
- Kinase insert domain receptor (links | edit)
- VEGFR (redirect page) (links | edit)
- Calreticulin (links | edit)
- Thalidomide (links | edit)
- Angiogenesis (links | edit)
- Hepatocellular carcinoma (links | edit)
- Angiostatin (links | edit)
- Itraconazole (links | edit)
- 2-Methoxyestradiol (links | edit)
- Lymphangioleiomyomatosis (links | edit)
- Angiogenesis inhibitor (links | edit)
- Endostatin (links | edit)
- Boehringer Ingelheim (links | edit)
- Sorafenib (links | edit)
- Osteonectin (links | edit)
- Protein kinase inhibitor (links | edit)
- ANGPT2 (links | edit)
- Alpha-v beta-3 (links | edit)
- SUGEN (links | edit)
- Icrucumab (links | edit)
- Brivanib alaninate (links | edit)
- List of antineoplastic agents (links | edit)
- RET inhibitor (links | edit)
- Fast endophilin-mediated endocytosis (links | edit)
- User:ProteinBoxBot/PBB Log Wiki 10-30-2007 A (links | edit)
- User:Fuse809/sandbox4 (links | edit)
- Template:Antiangiogenics (links | edit)
- Angiozyme (links | edit)
- Axitinib (links | edit)
- Colony stimulating factor 1 receptor (links | edit)
- VEGFR-3 (redirect page) (links | edit)
- VEGF r (redirect page) (links | edit)
- Flt-4 (redirect page) (links | edit)
- Articular cartilage repair (links | edit)
- Extranodal NK/T-cell lymphoma, nasal type (links | edit)
- Vascular endothelial growth factor receptors (redirect page) (links | edit)
- Ingression (biology) (links | edit)
- Tivozanib (links | edit)
- Soluble vascular endothelial growth factor receptor (redirect page) (links | edit)
- Motesanib (links | edit)
- C-Met inhibitor (links | edit)
- VEGFR inhibitor (redirect to section "VEGFR antagonists") (links | edit)
- Hematopoietic stem cell niche (links | edit)
- Vasculogenic mimicry (links | edit)
- Anti-VEGF (links | edit)
- VEGF receptors (redirect page) (links | edit)
- Chemotherapy (links | edit)
- Janus kinase (links | edit)
- Tyrosine kinase (links | edit)
- Metabotropic receptor (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- Imatinib (links | edit)
- Guanylate cyclase (links | edit)
- Insulin receptor (links | edit)
- Trastuzumab (links | edit)
- ATC code L (links | edit)
- ATC code L01 (links | edit)
- Gefitinib (links | edit)
- Rituximab (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Vascular endothelial growth factor (links | edit)
- Epidermal growth factor receptor (links | edit)
- Soluble fms-like tyrosine kinase-1 (links | edit)
- ABL (gene) (links | edit)
- Erlotinib (links | edit)
- Ibritumomab tiuxetan (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- Alemtuzumab (links | edit)
- Gemtuzumab ozogamicin (links | edit)
- HER2 (links | edit)
- Targeted therapy (links | edit)
- Sorafenib (links | edit)
- Tyrosin-protein kinase Lck (links | edit)
- Sunitinib (links | edit)
- MuSK protein (links | edit)
- Guanylate cyclase 2C (links | edit)
- Lapatinib (links | edit)
- ROR2 (links | edit)
- Tropomyosin receptor kinase A (links | edit)
- Tropomyosin receptor kinase B (links | edit)
- Low-affinity nerve growth factor receptor (links | edit)
- Tropomyosin receptor kinase C (links | edit)
- Insulin-like growth factor 1 receptor (links | edit)
- Receptor tyrosine kinase (links | edit)
- Ephrin receptor (links | edit)
- BMPR2 (links | edit)
- Erythropoietin receptor (links | edit)
- Somatomedin receptor (links | edit)
- Bone morphogenetic protein receptor, type 1 (links | edit)
- Activin type 1 receptors (links | edit)
- Platelet-derived growth factor receptor (links | edit)
- Activin type 2 receptors (links | edit)
- Bone morphogenetic protein receptor (links | edit)
- Fibroblast growth factor receptor (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- Denileukin diftitox (links | edit)
- Tositumomab (links | edit)
- Bruton's tyrosine kinase (links | edit)
- Monoclonal antibody therapy (links | edit)
- Panitumumab (links | edit)
- ZAP70 (links | edit)
- Vandetanib (links | edit)
- Tyrosine-protein kinase SYK (links | edit)
- Edrecolomab (links | edit)
- Pertuzumab (links | edit)
- Catumaxomab (links | edit)
- Ipilimumab (links | edit)
- Tremelimumab (links | edit)
- KIT (gene) (links | edit)
- TGF beta receptor (links | edit)
- Inotuzumab ozogamicin (links | edit)
- Ofatumumab (links | edit)
- Semaxanib (links | edit)
- TGF beta receptor 1 (links | edit)
- TGF beta receptor 2 (links | edit)
- Enzyme-linked receptor (links | edit)
- Protein kinase inhibitor (links | edit)
- Fibroblast growth factor receptor 2 (links | edit)
- Insulin-like growth factor 2 receptor (links | edit)
- ITK (gene) (links | edit)
- Cediranib (links | edit)
- VEGF receptor (links | edit)
- Angiopoietin receptor (links | edit)
- Related to receptor tyrosine kinase (links | edit)
- RET proto-oncogene (links | edit)
- CD135 (links | edit)
- Tir (receptor) (links | edit)
- Fibroblast growth factor receptor 1 (links | edit)
- Fibroblast growth factor receptor 3 (links | edit)
- Pazopanib (links | edit)
- Growth factor receptor (links | edit)
- Activin receptor (links | edit)
- Tyrosine kinase 2 (links | edit)
- Janus kinase 3 (links | edit)
- Janus kinase 2 (links | edit)
- Janus kinase 1 (links | edit)
- ErbB (links | edit)
- Temsirolimus (links | edit)
- GUCY2D (links | edit)
- FYN (links | edit)
- LYN (links | edit)
- PTK2 (links | edit)
- VEGFR1 (links | edit)
- PDGFRB (links | edit)
- Kinase insert domain receptor (links | edit)
- HCK (links | edit)
- ERBB3 (links | edit)
- ERBB4 (links | edit)
- Fibroblast growth factor receptor 4 (links | edit)
- PTK2B (links | edit)
- Proto-oncogene tyrosine-protein kinase Src (links | edit)
- Vascular endothelial growth factor C (links | edit)
- TEK tyrosine kinase (links | edit)
- EPH receptor B2 (links | edit)
- Trk receptor (links | edit)
- NPR1 (links | edit)
- NPR2 (links | edit)
- Receptor protein serine/threonine kinase (links | edit)
- EPH receptor A2 (links | edit)
- Axitinib (links | edit)
- Colony stimulating factor 1 receptor (links | edit)
- Tyrosine-protein kinase Yes (links | edit)
- FGR (gene) (links | edit)
- Anaplastic lymphoma kinase (links | edit)
- Tyrosine-protein kinase Fes/Fps (links | edit)
- EPH receptor B4 (links | edit)
- DDR1 (links | edit)
- Thrombopoietin receptor (links | edit)
- AXL receptor tyrosine kinase (links | edit)
- TEC (gene) (links | edit)
- ABL2 (links | edit)
- MST1R (links | edit)
- EPH receptor A4 (links | edit)
- TNK2 (links | edit)
- EPH receptor B1 (links | edit)
- Megakaryocyte-associated tyrosine kinase (links | edit)
- FER (gene) (links | edit)
- PTK6 (links | edit)
- BMX (gene) (links | edit)
- EPH receptor A3 (links | edit)
- EPHB6 (links | edit)
- EPHA8 (links | edit)
- EPHA7 (links | edit)
- EPH receptor A5 (links | edit)
- MERTK (links | edit)
- Discoidin domain-containing receptor 2 (links | edit)
- TYRO3 (links | edit)
- EPH receptor A1 (links | edit)
- EPHB3 (links | edit)
- Tyrosine-protein kinase BLK (links | edit)
- ROS1 (links | edit)
- EPHA6 (links | edit)
- TXK (gene) (links | edit)
- Leukocyte receptor tyrosine kinase (links | edit)
- INSRR (links | edit)
- Fyn-related kinase (links | edit)
- STYK1 (links | edit)
- PTK7 (links | edit)
- AATK (links | edit)
- FLT4 (links | edit)
- Ciliary neurotrophic factor receptor (links | edit)
- Platelet-derived growth factor receptor A (links | edit)
- Ridaforolimus (links | edit)
- Lestaurtinib (links | edit)
- LMTK2 (links | edit)
- Bosutinib (links | edit)
- Aflibercept (links | edit)
- Elotuzumab (links | edit)
- Blinatumomab (links | edit)
- TIE1 (links | edit)
- Afatinib (links | edit)
- Neurotrophic factor receptor (links | edit)
- Ramucirumab (links | edit)
- Obinutuzumab (links | edit)
- Non-receptor tyrosine kinase (links | edit)
- Vatalanib (links | edit)
- Neratinib (links | edit)
- Necitumumab (links | edit)
- Oportuzumab monatox (links | edit)
- RTK class III (links | edit)
- Cell surface receptor (links | edit)
- Toceranib (links | edit)
- Lenvatinib (links | edit)
- Regorafenib (links | edit)
- Apatinib (links | edit)
- Brentuximab vedotin (links | edit)
- CDK inhibitor (links | edit)
- Olaratumab (links | edit)
- Mubritinib (links | edit)
- Erbulozole (links | edit)
- Tyrosine kinase inhibitor (links | edit)
- Crizotinib (links | edit)
- Tivozanib (links | edit)
- ROR1 (links | edit)
- Receptor tyrosine kinase-like orphan receptor (links | edit)
- Vemurafenib (links | edit)
- Src family kinase (links | edit)
- Guanylate cyclase-coupled receptor (links | edit)
- Receptor tyrosine phosphatase (links | edit)
- Quizartinib (links | edit)
- Trastuzumab emtansine (links | edit)
- Midostaurin (links | edit)
- Ruxolitinib (links | edit)
- Nintedanib (links | edit)
- Cabozantinib (links | edit)
- Ponatinib (links | edit)
- Vismodegib (links | edit)
- Selumetinib (links | edit)
- Brigatinib (links | edit)
- Chemotherapy-induced nausea and vomiting (links | edit)
- Mogamulizumab (links | edit)
- Moxetumomab pasudotox (links | edit)
- Daratumumab (links | edit)
- MiR-296 (links | edit)
- Prohibitin-targeting peptide 1 (links | edit)
- Fedratinib (links | edit)
- Momelotinib (links | edit)
- Ibrutinib (links | edit)
- Nivolumab (links | edit)
- Masitinib (links | edit)
- Trametinib (links | edit)
- Dabrafenib (links | edit)
- Margetuximab (links | edit)
- Encorafenib (links | edit)
- Pembrolizumab (links | edit)
- Palbociclib (links | edit)
- Tyrosine-protein kinase CSK (links | edit)
- Cobimetinib (links | edit)
- Growth factor receptor inhibitor (links | edit)
- Pacritinib (links | edit)
- Radotinib (links | edit)
- Icotinib (links | edit)
- Zolbetuximab (links | edit)
- Sonidegib (links | edit)
- Dacomitinib (links | edit)
- Ceritinib (links | edit)
- Resminostat (links | edit)
- Filgotinib (links | edit)
- Dinutuximab (links | edit)
- Binimetinib (links | edit)
- Tucidinostat (links | edit)
- Enfortumab vedotin (links | edit)
- Polatuzumab vedotin (links | edit)
- Durvalumab (links | edit)
- Isatuximab (links | edit)
- Atezolizumab (links | edit)
- Sacituzumab govitecan (links | edit)
- Osimertinib (links | edit)
- List of antineoplastic agents (links | edit)
- Avelumab (links | edit)
- Venetoclax (links | edit)
- Acalabrutinib (links | edit)
- Alectinib (links | edit)
- Pexidartinib (links | edit)
- Mirvetuximab soravtansine (links | edit)
- Rociletinib (links | edit)
- Entrectinib (links | edit)
- Pathophysiology of Parkinson's disease (links | edit)
- TGF-beta receptor family (links | edit)
- Bermekimab (links | edit)
- Capmatinib (links | edit)
- Tesevatinib (links | edit)
- Tislelizumab (links | edit)
- Olmutinib (links | edit)
- Lorlatinib (links | edit)
- Glasdegib (links | edit)
- Larotrectinib (links | edit)
- Tucatinib (links | edit)
- Savolitinib (links | edit)
- Erdafitinib (links | edit)
- Sitravatinib (links | edit)
- Silmitasertib (links | edit)
- Gilteritinib (links | edit)
- Loncastuximab tesirine (links | edit)
- Cemiplimab (links | edit)
- Ivosidenib (links | edit)
- Tepotinib (links | edit)
- Dostarlimab (links | edit)
- Camrelizumab (links | edit)
- Zanubrutinib (links | edit)
- Sotorasib (links | edit)
- Abrocitinib (links | edit)
- Trastuzumab deruxtecan (links | edit)
- Avapritinib (links | edit)
- Pemigatinib (links | edit)
- Selpercatinib (links | edit)
- Ripretinib (links | edit)
- Pertuzumab/trastuzumab/hyaluronidase (links | edit)
- Tafasitamab (links | edit)
- Belantamab mafodotin (links | edit)
- Trastuzumab/hyaluronidase (links | edit)
- Pralsetinib (links | edit)
- Naxitamab (links | edit)
- Mobocertinib (links | edit)
- Adagrasib (links | edit)
- Amivantamab (links | edit)
- Infigratinib (links | edit)
- Tirabrutinib (links | edit)
- Tisotumab vedotin (links | edit)
- Asciminib (links | edit)
- Tebentafusp (links | edit)
- Nivolumab/relatlimab (links | edit)
- Mosunetuzumab (links | edit)
- Teclistamab (links | edit)
- Futibatinib (links | edit)
- Pirtobrutinib (links | edit)
- Talquetamab (links | edit)
- Inavolisib (links | edit)
- Retifanlimab (links | edit)
- Glofitamab (links | edit)
- Epcoritamab (links | edit)
- Elranatamab (links | edit)
- Toripalimab (links | edit)
- Fruquintinib (links | edit)
- Capivasertib (links | edit)
- Repotrectinib (links | edit)
- Patritumab deruxtecan (links | edit)
- Envafolimab (links | edit)
- Odronextamab (links | edit)
- Tarlatamab (links | edit)
- Parsaclisib (links | edit)
- Aumolertinib (links | edit)
- Surufatinib (links | edit)
- Orelabrutinib (links | edit)
- Tovorafenib (links | edit)
- Sugemalimab (links | edit)
- Lazertinib (links | edit)
- Vimseltinib (links | edit)
- Atezolizumab/hyaluronidase (links | edit)
- Serplulimab (links | edit)
- Tunlametinib (links | edit)
- Revumenib (links | edit)
- Zanidatamab (links | edit)
- Zenocutuzumab (links | edit)
- Cosibelimab (links | edit)
- Ensartinib (links | edit)
- Nivolumab/hyaluronidase (links | edit)
- Talk:Vatalanib (links | edit)
- Talk:VEGF receptors (transclusion) (links | edit)
- User:Andrew Su/Merge candidates (links | edit)
- User:Andrew Su/ITK (gene) (links | edit)
- User:Mikael Häggström/Gallery (links | edit)
- User:Chaos/Books/Pharmacology (links | edit)
- User:Chaos/Books/Pharmc (links | edit)
- User:Fvasconcellos/T-DM1 (links | edit)
- User:Drhovsky/Books/OBP (links | edit)
- User:Augustosepulveda/Books/Renal Cell Carcinoma (links | edit)
- User:Jlong74/sandbox (links | edit)
- User:Immcarle146/sandbox (links | edit)
- User:Y-S.Ko/Wikipedia course/Medical/Oncology (links | edit)
- User:Y-S.Ko/Wikipedia course/Pharmacology/L-V (links | edit)
- User:Noxoug1/Tovorafenib (links | edit)
- User:Noxoug1/template-product (links | edit)
- User:Noxoug1/Lazertinib-template (links | edit)
- Misplaced Pages:Recent additions 235 (links | edit)
- Misplaced Pages:Recent additions/2008/November (links | edit)
- Template:Receptor tyrosine kinases (links | edit)
- Template:Tyrosine kinases (links | edit)
- Template:Growth factor receptors (links | edit)
- Template:Targeted cancer therapeutic agents (links | edit)
- Template:Enzyme-linked receptors (links | edit)
- Lucitanib (links | edit)
- TMCO4 (links | edit)
- VEGFR-2 inhibitor (links | edit)
- Metronomic therapy (links | edit)
- Princess Imoukhuede (links | edit)
- Talk:VEGF receptor (transclusion) (links | edit)
- User:The Anome/Cancer dictionary test (links | edit)
- User:Mikael Häggström/Article creations (links | edit)
- User:Wikihop1 (links | edit)
- User:Ron130/Books/Kinasese in Cancer (links | edit)
- User:Kwelgan/sandbox (links | edit)
- User:Vmsv/sandbox (links | edit)
- User:Sookyoung/sandbox (links | edit)
- User:Jgsrosa1/Colony stimulating factor 1 receptor (links | edit)
- User:Kashydan/Vasculogenic mimicry (links | edit)